NXEN

Nexien BioPharma (QB) (NXEN)

Nexien BioPharma Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:NXEN

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	00 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2024/05/29	00 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2024/05/15	19 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:NXEN	Nexien BioPharma Inc (QB)
2024/02/20	20 : 19	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:NXEN	Nexien BioPharma Inc (QB)
2024/02/14	20 : 04	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/11/03	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/11/03	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/09/28	19 : 06	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/08/01	06 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/08/01	04 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/05/16	04 : 35	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/04/20	07 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/04/20	05 : 17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/02/08	20 : 18	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/01/18	03 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2023/01/18	03 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/11/09	20 : 22	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/10/19	01 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/10/19	00 : 05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/09/16	05 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/09/15	06 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/09/15	06 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/05/13	01 : 36	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/02/08	20 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/02/01	05 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2022/01/22	03 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2021/11/30	02 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2021/11/30	02 : 21	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2021/11/22	23 : 57	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:NXEN	Nexien BioPharma Inc (QB)
2021/10/12	19 : 16	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:NXEN	Nexien BioPharma Inc (QB)